Literature DB >> 19739693

Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease.

Theresa A Zesiewicz1, Marian L Evatt.   

Abstract

Nearly two-thirds of patients with Parkinson's disease (PD) use vitamins or nutritional supplements, and many more may use other complementary therapies, yet <50% of patients have discussed the use of these complementary therapies with a healthcare professional. Physicians should be aware of the complementary therapies their patients with PD are using, and the possible effects of these therapies on motor and non-motor symptoms. Complementary therapies, such as altered diet, dietary supplements, vitamin therapy, herbal supplements, caffeine, nicotine, exercise, physical therapy, massage therapy, melatonin, bright-light therapy and acupuncture, may all influence the symptoms of PD and/or the effectiveness of dopaminergic therapy. Preliminary evidence suggests complementary therapy also may influence non-motor symptoms of PD, such as respiratory disorders, gastrointestinal disorders, mood disorders, sleep and orthostatic hypotension. Whenever possible, clinicians should ensure that complementary therapy is used appropriately in PD patients without reducing the benefits of dopaminergic therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19739693     DOI: 10.2165/11310860-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  136 in total

1.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

Review 2.  Optimal protein intake in the elderly.

Authors:  Robert R Wolfe; Sharon L Miller; Kevin B Miller
Journal:  Clin Nutr       Date:  2008-09-25       Impact factor: 7.324

3.  Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease.

Authors:  Y Sato; S Manabe; H Kuno; K Oizumi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  The effect of folic acid fortification on plasma folate and total homocysteine concentrations.

Authors:  P F Jacques; J Selhub; A G Bostom; P W Wilson; I H Rosenberg
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

Review 6.  Nicotine and Parkinson's disease: implications for therapy.

Authors:  Maryka Quik; Kathryn O'Leary; Caroline M Tanner
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

7.  A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

Authors: 
Journal:  Clin Neuropharmacol       Date:  2008 May-Jun       Impact factor: 1.592

8.  Chronic high dose transdermal nicotine in Parkinson's disease: an open trial.

Authors:  G Villafane; P Cesaro; A Rialland; S Baloul; S Azimi; C Bourdet; J Le Houezec; I Macquin-Mavier; P Maison
Journal:  Eur J Neurol       Date:  2007-10-17       Impact factor: 6.089

Review 9.  Adherence to Mediterranean diet and health status: meta-analysis.

Authors:  Francesco Sofi; Francesca Cesari; Rosanna Abbate; Gian Franco Gensini; Alessandro Casini
Journal:  BMJ       Date:  2008-09-11

10.  Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial.

Authors:  Jennifer J Watts; Jennifer L McGinley; Frances Huxham; Hylton B Menz; Robert Iansek; Anna T Murphy; Emma R Waller; Meg E Morris
Journal:  BMC Geriatr       Date:  2008-09-30       Impact factor: 3.921

View more
  9 in total

Review 1.  Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

Authors:  Naveen Kumar Singhal; Garima Srivastava; Sonal Agrawal; Swatantra Kumar Jain; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2011-12-24       Impact factor: 5.590

2.  Improved methods for electroacupuncture and electromyographic recordings in normal and parkinsonian rhesus monkeys.

Authors:  Feng Zhao; Xiaotong Fan; Richard Grondin; Ramsey Edwards; Eric Forman; Jennifer Moorehead; Greg Gerhardt; Xiaomin Wang; Zhiming Zhang
Journal:  J Neurosci Methods       Date:  2010-07-21       Impact factor: 2.390

3.  A mechatronic system for quantitative application and assessment of massage-like actions in small animals.

Authors:  Qian Wang; Hansong Zeng; Thomas M Best; Caroline Haas; Ned T Heffner; Sudha Agarwal; Yi Zhao
Journal:  Ann Biomed Eng       Date:  2013-08-14       Impact factor: 3.934

Review 4.  A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease.

Authors:  Liang Song; Meng-Bei Xu; Xiao-Li Zhou; Dao-Pei Zhang; Shu-Ling Zhang; Guo-Qing Zheng
Journal:  Oxid Med Cell Longev       Date:  2017-03-13       Impact factor: 6.543

Review 5.  Role of Dietary Supplements in the Management of Parkinson's Disease.

Authors:  Michele Ciulla; Lisa Marinelli; Ivana Cacciatore; Antonio Di Stefano
Journal:  Biomolecules       Date:  2019-07-10

6.  Effectiveness of 6-Week Nordic Walking Training on Functional Performance, Gait Quality, and Quality of Life in Parkinson's Disease.

Authors:  Justyna Szefler-Derela; Michal Arkuszewski; Andrzej Knapik; Dagmara Wasiuk-Zowada; Agnieszka Gorzkowska; Ewa Krzystanek
Journal:  Medicina (Kaunas)       Date:  2020-07-17       Impact factor: 2.430

7.  Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson's disease.

Authors:  Weidong Pan; Shin Kwak; Guoyan Li; Yiyun Chen; Dingfang Cai
Journal:  Chin Med       Date:  2013-07-27       Impact factor: 5.455

8.  Chinese herbal medicine paratherapy for Parkinson's disease: a meta-analysis of 19 randomized controlled trials.

Authors:  Yan Wang; Cheng-Long Xie; Lin Lu; Deng-Lei Fu; Guo-Qing Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-13       Impact factor: 2.629

Review 9.  Evidence Supports PA Prescription for Parkinson's Disease: Motor Symptoms and Non-Motor Features: A Scoping Review.

Authors:  Yi-Chen Cheng; Chun-Hsien Su
Journal:  Int J Environ Res Public Health       Date:  2020-04-22       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.